Compare INVA & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | BELFA |
|---|---|---|
| Founded | 1996 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2004 | N/A |
| Metric | INVA | BELFA |
|---|---|---|
| Price | $20.77 | $141.72 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $36.60 | N/A |
| AVG Volume (30 Days) | ★ 929.9K | 27.7K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | ★ 53.96 | 19.52 |
| EPS | 1.52 | ★ 5.17 |
| Revenue | $388,521,000.00 | ★ $649,376,000.00 |
| Revenue This Year | $13.23 | $28.52 |
| Revenue Next Year | $8.62 | $6.49 |
| P/E Ratio | ★ $13.61 | $27.53 |
| Revenue Growth | 10.14 | ★ 23.70 |
| 52 Week Low | $16.52 | $53.95 |
| 52 Week High | $22.76 | $142.82 |
| Indicator | INVA | BELFA |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 64.07 |
| Support Level | $20.64 | $114.02 |
| Resistance Level | $21.93 | $129.90 |
| Average True Range (ATR) | 0.61 | 4.95 |
| MACD | -0.20 | 1.80 |
| Stochastic Oscillator | 15.22 | 98.16 |
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.